Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Hammami, S ^a   Boutiba Ben Boubaker, I ^a,b   Ghozzi, R ^a,b   Saidani, M ^a,b   Amine, S ^a,b   Ben Redjeb, S ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Carbapenem; Epidemiology; P. aeruginosa; Pulsed field gel electrophoresis

Indexed keywords

BETA LACTAMASE; IMIPENEM; VIM 2 BETA LACTAMASE; VIM-2 BETA-LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CROSS INFECTION; ENZYMOLOGY; EPIDEMIC; GENETICS; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; STATISTICS; TUNISIA;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITAL UNITS; HUMANS; IMIPENEM; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TUNISIA;

EID: 80054988925     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-106     Document Type: Article

References (39)

1. Kohlenberg A, Weitzel-Kage D, van der Linden P, Sohr D, Vogeler S, Kola A, Halle E, Ruden H, Weist K. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. J Hosp Infect 2010, 74:350-357. 10.1016/j.jhin.2009.10.024, 20170982.
2. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 2000, 31:1119-1125. 10.1086/317448, 11073738.
3. Tsakris A, Pournaras S, Woodford N, Palepou MF, Babini GS, Douboyas J, Livermore DM. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 2000, 38:1290-1292. 88610, 10699045.
4. Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006, 50:43-48. 10.1128/AAC.50.1.43-48.2006, 1346794, 16377665.
5. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005, 11(Suppl 4):17-32.
6. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa a systematic review of the literature. J Hosp Infect 2006, 64:7-15. 10.1016/j.jhin.2006.04.015, 16822583.
7. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect 2005, 59:96-101. 10.1016/j.jhin.2004.09.007, 15620442.
8. Livermore DM, Woodford N. Carbapenemases: a problem in waiting?. Curr Opin Microbiol 2000, 3:489-495. 10.1016/S1369-5274(00)00128-4, 11050448.
9. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 2005, 18:306-325. 10.1128/CMR.18.2.306-325.2005, 1082798, 15831827.
10. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458. 10.1128/CMR.00001-07, 1932750, 17630334.
11. Murphy TA, Simm AM, Toleman MA, Jones RN, Walsh TR. Biochemical characterization of the acquired metallo-β-lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob Agents Chemother 2003, 47:582-587. 10.1128/AAC.47.2.582-587.2003, 151762, 12543663.
12. Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother 2004, 48:4654-4661. 10.1128/AAC.48.12.4654-4661.2004, 529189, 15561840.
13. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005, 49:4485-4491. 10.1128/AAC.49.11.4485-4491.2005, 1280121, 16251286.
14. Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 2008, 17:131-143. 10.1517/13543784.17.2.131, 18230049.
15. Sekiguchi J, Morita K, Kitao T, Watanabe N, Okazaki M, Miyoshi-Akiyama T, Kanamori M, Kirikae T. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob Agents Chemother 2008, 52:4194-4197. 10.1128/AAC.01337-07, 2573105, 18765691.
16. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53:5046-5054. 10.1128/AAC.00774-09, 2786356, 19770275.
17. Poirel L, Rodriguez-Martinez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P. Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob Agents Chemother 2010, 54:2420-2424. 10.1128/AAC.01456-09, 2876379, 20308383.
18. Hammami S, Gautier V, Ghozzi R, Da Costa A, Ben-Redjeb S, Arlet G. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect 2010, 16:189-193. 10.1111/j.1469-0691.2009.03023.x, 19686278.
19. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth information supplement. M100-S16 2006, Wayne, PA: CLSI, Clinical and Laboratory Standards Institute.
20. Pitout JD, Chow BL, Gregson DB, Laupland KB, Elsayed S, Church DL. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J Clin Microbiol 2007, 45:294-298. 10.1128/JCM.01694-06, 1829051, 17122002.
21. Yatsuyanagi J, Saito S, Ito Y, Ohta K, Kato J, Harata S, Suzuki N, Amano K. Identification of Pseudomonas aeruginosa clinical strains harboring the blaVIM-2 metallo-β-lactamase gene in Akita Prefecture, Japan. Jpn J Infect Dis 2004, 57:130-132.
22. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, Wu JJ. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001, 45:2224-2228. 10.1128/AAC.45.8.2224-2228.2001, 90635, 11451678.
23. Patzer JA, Dzierzanowska D. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002). Int J Antimicrob Agents 2007, 29:153-158. 10.1016/j.ijantimicag.2006.08.044, 17157481.
24. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239. 228385, 7494007.
25. Cezario RC, Duarte De Morais L, Ferreira JC, Costa-Pinto RM, da Costa Darini AL, Gontijo-Filho PP. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin 2009, 27:269-274. 10.1016/j.eimc.2008.09.009, 19386392.
26. Kalai S, Achour W, Abdeladhim A, Bejaoui M, Ben Hassen A. Pseudomonas aeruginosa isolés de patients immunodéprimés: résistance aux antibiotiques, sérotypage et typage moléculaire. Med Mal Infect 2005, 35:530-535. 10.1016/j.medmal.2005.08.006, 16309870.
27. Ben Abdallah H, Noomen S, Khelifa AB, Sahnoun O, Elargoubi A, Mastouri M. Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia. Med Mal Infect 2008, 38:554-556. 10.1016/j.medmal.2008.05.002, 18814981.
28. Lamia T, Bousselmi K, Saida BR, Allah MA. Epidemiological profile and antibiotic susceptibility of Pseudomonas aeruginosa isolates within the burned patient hospitalized in the intensive care burn unit. Tunis Med 2007, 85:124-127.
29. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999, 33:960-967. 10.1345/aph.18426, 10492501.
30. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001, 47:247-250. 10.1093/jac/47.3.247, 11222556.
31. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:4783-4788. 10.1128/AAC.00574-09, 2772299, 19738025.
32. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 2005, 49:3538-3540. 10.1128/AAC.49.8.3538-3540.2005, 1196250, 16048978.
33. Toleman MA, Biedenbach D, Bennett DM, Jones RN, Walsh TR. Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 2005, 55:61-70.
34. Poirel L, Lambert T, Turkoglu S, Ronco E, Gaillard J, Nordmann P. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother 2001, 45:546-552. 10.1128/AAC.45.2.546-552.2001, 90325, 11158753.
35. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis 2009, 64:458-461. 10.1016/j.diagmicrobio.2009.04.003, 19631102.
36. Ktari S, Arlet G, Mnif B, Gautier V, Mahjoubi F, Ben Jmeaa M, Bouaziz M, Hammami A. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 2006, 50:4198-4201. 10.1128/AAC.00663-06, 1694011, 17015633.
37. Hammami S, Ghozzi R, Ben Ayed S, Ben Hassen A, Ben Rejeb S. Clonal spread of carbapenem resistant Pseudomonas aeuriginosa in an university hospital. Tunis Med 2008, 86:653-656.
38. Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, Szabo G, Fuzi M. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res Microbiol 2008, 159:162-168. 10.1016/j.resmic.2007.12.008, 18280707.
39. Pitout JD, Revathi G, Chow BL, Kabera B, Kariuki S, Nordmann P, Poirel L. Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin Microbiol Infect 2008, 14:755-759. 10.1111/j.1469-0691.2008.02030.x, 18727799.